About Molbio Diagnostics
The shares listed at ₹980.00, a 21.44% move from the issue price. Molbio Diagnostics is a Mainboard IPO with an issue size of ₹939.70 crore, proposed for listing on BSE, NSE. The offer opens on 10th Aug 2026 and closes on 12th Aug 2026. The issue structure includes a fresh issue of ₹200.00 crore and an offer-for-sale component of ₹739.70 crore. The current listing schedule points to 17th Aug 2026.
Company Contact
Address—
Phone—
Websitehttps://www.ipomatrix.com/